| Item Type | Name |
|
Concept
|
Deoxycytosine Nucleotides
|
|
Concept
|
Deoxyadenine Nucleotides
|
|
Concept
|
Adenine Nucleotides
|
|
Concept
|
Deoxyguanine Nucleotides
|
|
Academic Article
|
Determination of nicotinamide-adenine dinucleotide and thiazole-4-carboxamide-adenine dinucleotide in human leukocytes by reversed-phase high-performance liquid chromatography.
|
|
Academic Article
|
Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia.
|
|
Academic Article
|
Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias.
|
|
Academic Article
|
Clofarabine for the treatment of acute lymphoblastic leukemia.
|
|
Academic Article
|
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
|
|
Academic Article
|
Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia.
|
|
Academic Article
|
The role of clofarabine in acute myeloid leukemia.
|
|
Academic Article
|
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
|
|
Academic Article
|
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
|
|
Academic Article
|
Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older.
|
|
Academic Article
|
Clofarabine: past, present, and future.
|
|
Academic Article
|
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
|
|
Academic Article
|
Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.
|
|
Academic Article
|
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.
|
|
Academic Article
|
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients =60 years with newly diagnosed acute myeloid leukemia.
|
|
Academic Article
|
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
|
|
Academic Article
|
Purine Nucleosidase Phosphorylase (PNP): A novel target in leukemias and lymphomas.
|
|
Academic Article
|
Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.
|
|
Academic Article
|
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.
|
|
Academic Article
|
Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
|
|
Academic Article
|
Current and future management options for myelodysplastic syndromes.
|
|
Academic Article
|
Outpatient consolidation treatment with clofarabine in a phase 2 study of older adult patients with previously untreated acute myelogenous leukemia.
|
|
Academic Article
|
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.
|
|
Academic Article
|
Clofarabine in the treatment of myelodysplastic syndromes.
|
|
Academic Article
|
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
|
|
Academic Article
|
Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
|
|
Academic Article
|
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine).
|
|
Academic Article
|
Clofarabine combinations as acute myeloid leukemia salvage therapy.
|
|
Academic Article
|
Clofarabine in leukemia.
|
|
Academic Article
|
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia.
|
|
Academic Article
|
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia.
|
|
Academic Article
|
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
|
|
Academic Article
|
Clofarabine: emerging role in leukemias.
|
|
Academic Article
|
Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
|
|
Academic Article
|
Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
|
|
Academic Article
|
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for?Patients with Chronic Myelomonocytic Leukemia.
|
|
Academic Article
|
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.
|
|
Academic Article
|
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents.
|
|
Academic Article
|
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
|